-
-
-
-
-
-
-
Piper Sandler on Adeptus Biotechnologies (ADPT): 'Multiple MRD Drivers, Operational Efficiencies, and 2026 Execution'
-
-
-
-
-
-
-
Guggenheim Starts Adeptus Biotechnologies Corp. (ADPT) at Buy
-
-
-
-
-
-
-
Form SCHEDULE 13G/A Adaptive Biotechnologies Filed by: ARK Investment Management LLC
-
-
-
-
-
-
-
Adaptive Biotechnologies (ADPT) Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
-
-
-
-
-
-
-
Adeptus Biotechnologies Corp. (ADPT) PT Raised to $9 at BTIG
-
-
-
-
-
-
-
Form SC 13G/A Adaptive Biotechnologies Filed by: ARK Investment Management LLC
-
-
-
414,922 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

